Načítá se...

Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer

Prostate cancer (PCa) is the second leading cause of cancer-related death in males in the United States. Majority of prostate cancers are originally androgen-dependent and sensitive to androgen-deprivation therapy (ADT), however, most of them eventually relapse and progress into incurable castration...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell Cycle
Hlavní autoři: Zhang, Zhe, Chen, Long, Wang, Hexiang, Ahmad, Nihal, Liu, Xiaoqi
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4612397/
https://ncbi.nlm.nih.gov/pubmed/25927139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1041689
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!